This is clinically relevant because in May 2022, tirzepatide was approved in the USA to treat type 2 diabetes (Syed 2022)
Getting Started with Tirzepatide To start using tirzepatide, you need a good plan
PlexusDx Approach to Sustainable GLP-1 Therapy PlexusDx offers flexible, month-to-month semaglutide therapy at $189/mo month-to-month, or from $149/mo on the 6-month plan without membership fees or insurance requirements, allowing patients to commit to treatment duration that supports their goals
If this genetic variant is present in your PlexusDx results, the following tests and reports are commonly used to explore it further: Genetic Tests: Genetic Report: Regulatory note: The compound referenced on this page is not approved by the FDA for human use and is not sold, distributed, or endorsed by PlexusDx
Nevertheless, it generally follows this pattern: 1-2 hours: Appetite suppression and weight loss dont start immediately after the first dose of semaglutide
Remember: an informed user is a safe user
